ArticleLeukemia & lymphoma2020
Ibrutinib-based therapy for the treatment of marginal zone lymphoma with central nervous system involvement.
Fateeha Furqan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it